Collage of CBMM pictures

Funded by The National Institute of Biomedical Imaging and Bioengineering

We design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management.

Our Vision & Mission

What is Precision Medicine?

The "Precision Medicine" initiative was announced by President Obama in his 2016 State of the Union address.

The initiative aims to shift away from a generic treatment approach to customizing medications for individuals. This tailored approach ensures that patients receive the most effective and safe treatments by targeting the specific characteristics of their illness. 

CBM2 is contributing to the Precision Medicine initiative by developing advanced tools that can rapidly deliver crucial diagnostic and prognostic information, overcoming current testing limitations.

As President Obama envisioned, this initiative strives to deliver "the right treatment at the right time."


Metal compasses hover over a DNA model with red and blue spheres atop a grey cylindrical base.
Student giving tour in white lab suits

Plastics Engineering

Design and fabricate microfluidic and nanofluidic devices in thermoplastics.​

Learn about plastics engineering
A magnified view showcasing a textured spherical cell surrounded by smooth red blood cells.

Liquid Biopsy Analysis

Highly efficient isolation and molecular analysis (CTCs, EVs, cfDNA).

Learn about liquid biopsy analysis

CBM² Stories

CBM2 Calls KU ‘Home’

The team at CBM2 is excited to bring our efforts to The University of Kansas in August 2016. The Center will be based out of the Multidisciplinary Research Building (MRB) in the West District of KU’s Lawrence campus.

CBM2's Webinar Draws 99 Enthusiastic Participants

Following the insightful webinar on "Liquid Gold in Precision Medicine: Liquid-Based Biopsies for Cancer Detection and Monitoring," hosted by the Center of BioModular Multi-Scale Systems for Precision Medicine (CBM2), the ripple effect of knowledge spread far and wide.

CMB2 Graduate Student Quentin Jarrell Triumphs in KU 3 MT Competition

Quentin Jarrell, a master's student in bioengineering at the Center of BioModular Multiscale Systems for Precision Medicine (CBM2), has emerged victorious in the KU 3MT Competition. Jarrell claimed the first-place title with his impactful presentation titled "Unraveling our Genetic Puzzle."

CBM2 Engages Young Minds at the Carnival of Chemistry

CBM2 participated in the Carnival of Chemistry, November 19, 2023, a lively event hosted by the KU Department of Chemistry and the KU Chemistry Club.

Upcoming Events

Organization Statistics

Partnering Organizations
Supporting Universities
Neon-colored interconnected bio-structures in elongated hexagonal patterns. Representing BioModular Multi-Scale Systems for Precision Medicine

Work with us

The Center is excited to accept requests for collaboration projects with researchers in the biomedical and microfluidics community.

Collaboration & Service Projects